ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,142.15
-0.06%
Dow Jones
38,778.10
0.49%
Gold vs US Dollar
2,324.155
0.16%
Brent Oil
83.59
-0.37%
Bitcoin
65,282.94
-1.81%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Day One Biopharmaceuticals Inc (DAWN)

  7. Day One Biopharmaceuticals Inc (DAWN) News

Day One Biopharmaceuticals (DAWN)

Day One Biopharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:DAWN
DateTimeSourceHeadlineSymbolCompany
12/06/202421:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
12/06/202413:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/06/202421:58Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
30/05/202413:35Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
28/05/202423:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
24/05/202421:02Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/05/202423:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/05/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
16/05/202423:34Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
16/05/202423:21Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
14/05/202423:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
06/05/202421:35Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
06/05/202421:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
07/03/202421:19Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
29/02/202400:55Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
27/02/202421:27Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
20/02/202423:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
20/02/202423:14Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
16/02/202422:51Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/01/202413:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/01/202400:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
10/01/202400:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
08/01/202413:30Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
04/01/202421:06Edgar (US Regulatory)Form S-8 - Securities to be offered to employees in employee benefit plansNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/11/202323:26Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/11/202323:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
17/11/202312:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
16/11/202323:24Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:DAWNDay One Biopharmaceuticals Inc
15/11/202321:07Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:DAWNDay One Biopharmaceuticals Inc
06/11/202321:48Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:DAWNDay One Biopharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:DAWN

Your Recent History

BIT
S27176
Societe Generale Effekten
BIT
F18801
Vontobel Financial Produ...
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved